ATTO Attovia Therapeutics, Inc.
$22.79▲ +1.15%
Healthcare
Other
After hours
$22.79▲ +0.00%
Sep 11, 7:30 PM ET
Volume 175.8K
Avg Volume (10D) 188.0K
Key Metrics & Fundamentals
Market Cap
$1.04B
P/E Ratio
–
Div Yield
–%
52W Range
16.15 - 28.00
% vs 50 MA
–%
% vs 200 MA
–%
RSI-14
51.0
Free Cash Flow
-$16.86M
Gross Rev
$450,000
Gross Profit
$450,000
EBITDA
-$21.56M
COGS
–
Operating Exp
$22.25M
Operating Income
-$21.80M
EBIT
-$21.80M
Pretax Income
-$20.69M
Net Income
-$20.69M
EPS (Diluted)
-0.48
Price & Volume History
Loading chart…
Recent News
Attovia Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 3, 2026 8:05 PM
Attovia Therapeutics Q2 Net Loss Widens
MT Newswires · Sep 2, 2026 8:48 PM
Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
GlobeNewswire · Sep 2, 2026 8:05 PM
Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says
MT Newswires · Aug 31, 2026 3:16 PM
Deere upgraded, Lumentum initiated: Wall Street's top analyst calls
The Fly · Aug 31, 2026 1:45 PM
Here Are Monday’s Top Wall Street Analyst Research Calls: AGCO Corporation, Deere & Co., Edison International, Lumentum Holdings, PG&E, Sempra Energy, STAG Industrial, Ticketplus, and More
24/7 Wall St. · Aug 31, 2026 11:56 AM
Moderna Stock Carries A Market Value Its Revenue Does Not Support
Trefis · Aug 26, 2026 3:13 PM
Moderna Stock Had A Readout Waiting In Plain Sight
Trefis · Aug 24, 2026 7:01 PM
Moderna's Melanoma Result Landed On A Market Positioned The Other Way
Trefis · Aug 20, 2026 6:21 PM
Meet Attovia: The Clinical-Stage Biotech That Aims to Stop Chronic Itch at the Source
24/7 Wall St. · Aug 17, 2026 1:10 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ATTO's money flow as a full page
Social Sentiment
No Reddit posts found for ATTO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.